Results 141 to 150 of about 20,385 (185)

Relative Effects of Brachytherapy and Beam Radiation for DCIS on Subsequent Invasive Events. [PDF]

Biomedicines
O'Keefe TJ, Prionas ND, Wallace AM.
europepmc   +1 more source

Complete Data Analysis Workflow for Quantitative DIA Mass Spectrometry Using Nextflow. [PDF]

J Proteome Res
Perk M, Pietilä S, Välikangas T, Balint B, Suomi T, Elo LL.   +5 more
europepmc   +1 more source

Diagnostic value of automated breast volume scanner for breast ductal carcinoma in situ. [PDF]

Medicine (Baltimore)
Tian C, Wu J, Wang Z.
europepmc   +1 more source

Breast Cancer Polygenic Risk Score Associated with Outcomes after In Situ Breast Disease. [PDF]

Cancer Epidemiol Biomarkers Prev
Timbres J, Kohut K, Mavaddat N, Easton DF, Petridis C, Roylance R, Schmidt MK, Sawyer EJ.   +7 more
europepmc   +1 more source

Surgical margins in breast conserving surgery for ductal carcinoma in situ of the breast and clinical outcomes: a national audit with long term follow-up. [PDF]

EClinicalMedicine
Robertson JF, Sibbering DM, Ndebele Mahati SG, Gandhi A, Pinder SE, Clements K, Kearins O, Bliss J, Kilburn L.   +8 more
europepmc   +1 more source

Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression. [PDF]

J Pathol
Kader T, Zethoven M, Mahale S, Saunders H, Tjoeka L, Lehmann R, Jayawardana MW, Pang JM, Lesche D, Rajan N, Semple T, Lee JEA, Lupat R, Byrne DJ, Hughes S, Nguyen H, Lai S, Pechlivanis M, Craig O, Devereux L, House E, Jayasinghe SI, Kaufmann TL, Schwarz RF, Green AR, Miligy IM, Cummings M, Lakhani S, Campbell IG, Rakha E, Fox SB, Mann GB, Gorringe KL.   +32 more
europepmc   +1 more source

Development of DCIS

, 2013
openaire   +1 more source

Multimodal Imaging of Ductal Carcinoma In Situ: A Single-Center Study of 75 Cases. [PDF]

Med Sci (Basel)
Urraro F, Giordano N, Patanè V, Brunese MC, Varelli C, Russo C, Brunese L, Cappabianca S.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

DCIS and aromatase inhibitors

The Journal of Steroid Biochemistry and Molecular Biology, 2007
In patients with hormone receptor positive DCIS tamoxifen reduces recurrence rates by almost 50%. Few data are available with aromatase inhibitors from randomised studies. In the ATAC study there were three DCIS lesions in the anastrozole arm and four in the tamoxifen arm in the women with ER positive invasive cancer. In the MA17 study which randomised
J Michael, Dixon, Dana, Faratian, Sharon, White, Lorna, Renshaw, Juliette, Murray, Oliver, Young, E Jane, Macaskill, Linda, Williams, Jeremy, Thomas, Dean B, Evans   +9 more
openaire   +2 more sources